Abstract
RET codon 609 point mutations are rare and may predispose to aggressive medullary thyroid carcinoma (MTC). In a kindred with 15 carriers of the Cys609Ser RET mutation we observed no MTC before 17 years of age, no lymph node metastases before 30 years and no distant metastases before 60 years. Two patients developed pheochromocytoma and one had primary hyperparathyroidism as the first sign of the syndrome. In conclusion, at variance from what already known, in this large kindred the Cys609Ser RET mutation predispose to a scarcely aggressive, highly penetrant MTC and a low penetrance of pheochromocytoma and primary hyperparathyroidism.
References
Steiner AL, Goodman AD, Powers SR (1968) Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: multiple endocrine neoplasia, type 2. Medicine (Baltimore) 47:371–409. doi:10.1097/00005792-196809000-00001
Keiser HR, Beaven MA, Doppman J, Wells S Jr, Buja LM (1973) Sipple’s syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. Ann Intern Med 78:561–579
Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671. doi:10.1210/jc.86.12.5658
Machens A, Dralle H (2008) Familial prevalence and age of RET germline mutations: implications for screening. Clin Endocrinol 69:81–87
Patocs A, Klein I, Szilvasi A, Gergics P, Toth M, Valkusz Z, Forizs E, Igaz P, Al-Farhat Y, Tordai A, Varadi A, Racz K, Esik O (2006) Genotype–phenotype correlations in Hungarian patients with hereditary medullarythyroid cancer. Wien Klin Wochenschr 118:417–421. doi:10.1007/s00508-006-0635-9
Skába R, Dvoráková S, Václavíková E, Vlcek P, Frantlová M, Bendlová B (2006) The risk of medullary thyroid carcinoma in patients with Hirschsprung’s disease. Pediatr Surg Int 22:991–995. doi:10.1007/s00383-006-1785-6
Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW (2005) Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Horumon To Rinsho 63:676–682
Simon S, Pavel M, Hensen J, Berg J, Hümmer HP, Carbon R (2002) Multiple endocrine neoplasia 2A syndrome: surgical management. J Pediatr Surg 37:897–900. doi:10.1053/jpsu.2002.32906
Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H (2005) Advances in the management of hereditary medullary thyroid cancer. J Intern Med 257:50–59. doi:10.1111/j.1365-2796.2004.01423.x
Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H, Takahashi M (1999) Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene 18:3919–3922. doi:10.1038/sj.onc.1202742
Fattoruso O, Quadro L, Libroia A, Verga U, Lupoli G, Cascone E, Colantuoni VA (1998) GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma. Hum Mutat 1(Suppl):S167–S171
Acknowledgments
This study was supported by a grant from Ministero dell’Istruzione, Università e Ricerca No200734RMKE-002 (2008–2009 to C.M.) and PRIN 2006060473_003 (to G.O.). We also thank Mrs. Frances Anne Coburn for text editing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mian, C., Barollo, S., Zambonin, L. et al. Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation. Familial Cancer 8, 379–382 (2009). https://doi.org/10.1007/s10689-009-9250-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-009-9250-z